The report, titled “Global Interventional Cardiology Market 2017-2021” presents a detailed assessment of the global interventional cardiology market, which includes market indicators, market trends, and growth opportunities that will be prevalent in the market for the 2017-2021 period. The report covers the development of the interventional cardiology market across the regions of Americas, EMEA, and APAC.
The global market for interventional cardiology market is expected to rise at 7.15% CAGR between 2017 and 2021.
According to the report, increasing incidence of cardiac diseases and exploding geriatric population across the globe are primarily driving the interventional cardiology market. Interventional cardiology procedures are sought after due to the several advantages they offer over traditional procedures. Interventional cardiology procedures are generally non-invasive, which is the foremost benefit of these procedures over traditional procedures. These procedures mostly require one small incision for inserting the catheter and most interventional cardiology procedures do not require general anesthesia to be given to patients.
Moreover, advancement in technology, rising demand for myocardial infarction (MI) procedures, and favorable reimbursement policies are further favoring the growth of this market.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/938667
High cost of interventional cardiology surgeries is a major factor restraining the growth of this market. The complications associated with the use of interventional cardiology devices are also restraining the market’s growth. Due to this reason, interventional cardiology procedures are not suggested for all heart patients and decisions about performing interventional procedures are made on a case to case basis.
Moreover, stringent regulations for the approval of devices, pricing pressure on product manufacturers, and lack of product differentiation are also holding back the market’s growth.
Nevertheless, the market will be benefitted due to some of the development trends that are expected to come to the fore in the future. This includes introduction of bioabsorbable stents, growing popularity of hybrid procedures, increasing mergers and acquisitions among market players, and increased focus on emerging countries.
Some of the leading companies in the global interventional cardiology market include Aachen Resonance, Alvimedica, Arthesys, AtriCure, Biosensors International, BrosMed Medical, Cardionovum, Cook Medical, Elixir Medical, Gadelius Medical, Gore Medical, JOTEC, Medinol, Merit Medical Systems, Natec Medical, Reva Medical, Simeks Medical, Spectranetics, Svelte Medical, Terumo, US Endovascular, Acrostak, AngioScore, Asahi Intec, B. Braun, Biotronik, C.R. Bard, Coherex Medical, Cardiovascular Systems, Fortimedix, GaltNeedle Tech, Hexacath, Lepu Medical Technology, Meri Life Sciences, MicroPort Scientific, OptiMed, SHOCKWAVE Medical, Smiths Medical, STENTYS, Teleflex,Tokai Medical Products, and Volcano.
The report composed of 123 pages is a veritable tool to understand the proceedings of the global interventional cardiology market for the 2017-2021 period. The report covers the present scenario and growth opportunities for this market during the forecast period. The report presents the market size estimates based on revenue generated from number of interventional cardiology procedures carried out in hospitals and ambulatory surgical centers.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com